Hannah Kuchler

Hannah Kuchler, a Financial Times journalist, dives into the implications of Wegovy, a new weight-loss drug boasting impressive results but raising ethical concerns. She discusses the criticism surrounding its ability to truly address the roots of obesity. Joining her is Lauren Indvik, FT's fashion editor, who shares clever tips for discovering personal style while promoting sustainable fashion choices. From building a versatile wardrobe to mindful consumption, their insights are timely and thought-provoking, challenging the status quo in health and fashion.

Patrick Radden Keefe, an award-winning writer and author of *Empire of Pain*, joins FT’s global pharmaceutical correspondent, Hannah Kuchler. They delve into the Sackler family’s dark legacy tied to the opioid crisis, unraveling their role in promoting OxyContin. Keefe shares insights from his investigative research, exposing corruption and the chilling impact on public health. The discussion spans the ethics of billionaire philanthropy, the Sackler’s influence on art and activism, and the erosion of trust in the healthcare system due to their actions.

Hannah Kuchler, FT's pharmaceutical correspondent, dives deep into the shocking story of Insys Therapeutics, the first drugmaker executives imprisoned for their role in the opioid crisis. She reveals their disturbing bribery schemes aimed at getting doctors to prescribe dangerous fentanyl. The discussion highlights how aggressive marketing overwhelmed ethical practices, contributing directly to widespread addiction. Kuchler also discusses the crucial role of whistleblowers in bringing these legal battles to light and the continuing impact of this scandal on the pharmaceutical industry.